Katarzyna Palica,
Manuela Vorácová,
Susann Skagseth,
Anna Andersson Rasmussen,
Lisa Allander,
Madlen Hubert
et al.:
Metallo-β-Lactamase Inhibitor Phosphonamidate Monoesters
Bjarte Aarmo Lund,
Ane Molden Thomassen,
Trine Josefine Warg Carlsen,
Hanna-Kirsti Schrøder Leiros
:
Biochemical and biophysical characterization of the OXA-48-like carbapenemase OXA-436
Acta Crystallographica. Section F : Structural Biology and Crystallization Communications 2021
FULLTEKST /
ARKIV /
DOI
Mitchell Silk,
Jason R. Price,
Biswaranjan Mohanty,
Hanna-Kirsti Schrøder Leiros,
Bjarte Aarmo Lund,
Phillip E. Thompson
et al.:
Side-Chain Interactions in d/l Peptide Nanotubes: Studies by Crystallography, NMR Spectroscopy and Molecular Dynamics
Chemistry - A European Journal 2021
ARKIV /
DOI
Jolyn Pan,
Kjersti Lian,
Aili Sarre,
Hanna-Kirsti Schrøder Leiros,
Adele Kim Williamson
:
Bacteriophage origin of some minimal ATP-dependent DNA ligases: a new structure from Burkholderia pseudomallei with striking similarity to Chlorella virus ligase
Christopher Frøhlich,
João Alves Gama,
Klaus Harms,
Viivi H. A. Hirvonen,
Bjarte Aarmo Lund,
Marc W. van der Kamp
et al.:
Cryptic β-Lactamase Evolution Is Driven by Low β-Lactam Concentrations
Zeeshan Muhammad,
Susann Skagseth,
Marc Boomgaren,
Sundus Akhter,
Christopher Frøhlich,
Aya Ismael
et al.:
Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases
Bioorganic & Medicinal Chemistry 01. August 2020
ARKIV /
DOI
Adele Kim Williamson,
Hanna-Kirsti S. Leiros
:
Structural insight into DNA joining: from conserved mechanisms to diverse scaffolds
Nucleic Acids Research (NAR) 2020
ARKIV /
DOI
Hanna-Kirsti S. Leiros,
Ane Molden Thomassen,
Ørjan Samuelsen,
Carl-Fredrik Flach,
Stathis D. Kotsakis,
Joakim Larsson
:
Structural insights into the enhanced carbapenemase
efficiency of OXA-655 compared to OXA-10
Christopher Frøhlich,
Vidar Sørum,
Sandra Huber,
Ørjan Samuelsen,
Fanny Berglund,
Erik Kristiansson
et al.:
Structural and biochemical characterization of the environmental MBLs MYO-1, ECV-1 and SHD-1
Journal of Antimicrobial Chemotherapy 2020
ARKIV /
DOI
Ørjan Samuelsen,
Ove Alexander Høgmoen Åstrand,
Christopher Frøhlich,
Adam Heikal,
Susann Skagseth,
Trine Josefine Olsen Carlsen
et al.:
ZN148 Is a Modular Synthetic Metallo-beta-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In Vivo
Antimicrobial Agents and Chemotherapy 2020
ARKIV /
DATA /
DOI
Christopher Frøhlich,
Vidar Sørum,
Ane Molden Thomassen,
Pål Jarle Johnsen,
Hanna-Kirsti S. Leiros,
Ørjan Samuelsen
:
OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
Adele Kim Williamson,
Hanna-Kirsti S. Leiros
:
Structural intermediates of a DNA-ligase complex illuminate the role of the catalytic metal ion and mechanism of phosphodiester bond formation
Anthony Prandina,
Sylvie Radix,
Marc Le Borgne,
Lars Petter Jordheim,
Zineb Bousfiha,
Christopher Fröhlich
et al.:
Synthesis and biological evaluation of new dipicolylamine zinc chelators as metallo-β-lactamase inhibitors
Francesca Marcoccia,
Hanna-Kirsti S. Leiros,
Massimiliano Aschi,
Gianfranco Amicosante,
Mariagrazia Perilli
:
Exploring the role of L209 residue in the active site of NDM-1 a metallo-β-lactamase
Sundus Ahkter,
Bjarte Aarmo Lund,
Aya Ismael,
Manuel Langer,
Johan Isaksson,
Tony Christopeit
et al.:
A focused fragment library targeting the antibiotic resistance enzyme - Oxacillinase-48: Synthesis, structural evaluation and inhibitor design
European Journal of Medicinal Chemistry 2018
ARKIV /
DOI
Adele Kim Williamson,
Miriam Grgic,
Hanna-Kirsti S. Leiros
:
DNA binding with a minimal scaffold: structure-function analysis of Lig E DNA ligases
Nucleic Acids Research (NAR) 2018
ARKIV /
DOI
Ørjan Samuelsen,
Frank Hansen,
Bettina Aasnæs,
Henrik Hasman,
Bjarte Aarmo Lund,
Hanna-Kirsti S. Leiros
et al.:
Dissemination and Characteristics of a Novel Plasmid-Encoded Carbapenem-Hydrolyzing Class D β-Lactamase, OXA-436, Found in Isolates from Four Patients at Six Different Hospitals in Denmark
Antimicrobial Agents and Chemotherapy 2018
DOI
Bjarte Aarmo Lund,
Ane Molden Thomassen,
Birgit Helene Berg Nesheim,
Trine Josefine Olsen Carlsen,
Johan Isaksson,
Tony Christopeit
et al.:
The biological assembly of OXA‐48 reveals a dimer interface with high charge complementarity and very high affinity
The FEBS Journal 2018
DOI
Susann Skagseth,
Tony Christopeit,
Sundus Akhter,
Annette Bayer,
Ørjan Samuelsen,
Hanna-Kirsti S. Leiros
:
Structural insights into TMB-1 and the role of residues 119 and 228 in substrate and inhibitor binding
Antimicrobial Agents and Chemotherapy 2017
ARKIV /
DOI
Bjarte Aarmo Lund,
Ane Molden Thomassen,
Trine Josefine Olsen Carlsen,
Hanna-Kirsti S. Leiros
:
Structure, activity and thermostability investigations of OXA-163, OXA-181 and OXA-245 using biochemical analysis, crystal structures and differential scanning calorimetry analysis
Acta Crystallographica. Section F : Structural Biology and Crystallization Communications 2017
ARKIV /
DOI
Susann Skagseth,
Sundus Akhter,
Marianne H. Paulsen,
Muhammad Zeeshan,
Silje Lauksund,
Ørjan Samuelsen
et al.:
Metallo-β-lactamase inhibitors by bioisosteric replacement: preparation, activity and binding
European Journal of Medicinal Chemistry 2017
ARKIV /
DOI
Tony Christopeit,
Ke-Wu Yang,
Shao-Kang Yang,
Hanna-Kirsti S. Leiros
:
The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor
Acta Crystallographica. Section F : Structural Biology and Crystallization Communications 2016
ARKIV /
DOI
Bjarte Aarmo Lund,
Tony Christopeit,
Yngve Guttormsen,
Annette Bayer,
Hanna-Kirsti S. Leiros
:
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening
Journal of Medicinal Chemistry 11. May 2016
ARKIV /
DOI
Christopher Frøhlich,
Hanna-Kirsti S. Leiros
:
Vi må kanskje ta antibiotika hyppigere
Daniel Salamonsen,
Christopher Fröhlich,
Hanna-Kirsti S. Leiros
:
Co-selection reduces functional trade-offs in the carbapenemase OXA-48
2022
Christopher Frøhlich,
Adrian H. Bunzel,
Marc W. Van Der Kamp,
Adrian J. Mulholland,
Hanna-Kirsti Schrøder Leiros,
Pål Jarle Johnsen
et al.:
Positive epistasis drives the molecular evolution of the carbapenemase OXA-48
2022
Hanna-Kirsti S. Leiros
:
Kor ofte skal du ta antibiotika? Kanskje oftare enn vi gjer no, ifølge forskarar
Klara Stensvåg,
Arnfinn Sundsfjord,
Pål Jarle Johnsen,
Hanna-Kirsti S. Leiros,
Lise Nordgård
:
CANS - Centre for New Antibacterial Strategies
Mitchell Silk,
Jason R. Price,
Biswaranjan Mohanty,
Hanna-Kirsti Schrøder Leiros,
Bjarte Aarmo Lund,
Philip E. Thompson
et al.:
Side-Chain Interactions in d/l Peptide Nanotubes: Studies by Crystallography, NMR Spectroscopy and Molecular Dynamics
Chemistry - A European Journal 2021
DOI
Christopher Frøhlich,
Hanna-Kirsti S. Leiros,
Charlotte Miton,
Nobuhiko Tokuriki
:
Ceftazidime drives the evolution of the carbapenemase OXA-48
2020
Hanna-Kirsti S. Leiros
:
På Labben med Forskningsdagene 2020. På Institutt for kjemi, UiT. "Proteiner som gjør at bakterier er resistente mot antibiotika".
Tore Rasmussen Steien,
Hanna-Kirsti S. Leiros
:
Kjemikerne prøver å stoppe kjeften på antibiotikadreperne
Norsk Farmaceutisk Tidsskrift 18. February 2020
DATA
Hanna-Kirsti S. Leiros
:
Vil ha 40 prosent kvinner i toppstillingar
Christopher Frøhlich,
Hanna-Kirsti S. Leiros,
Pål Jarle Johnsen,
Ørjan Samuelsen
:
Sub-inhibitory concentrations of ceftazidime drive evolution of the OXA-48 carbapenemase
2019
Hanna-Kirsti S. Leiros
:
Inhibitor potential of Serine- and Metallo-beta-lactamase inhibitors, and Biochemical and Biophysical characterization
Hanna-Kirsti S. Leiros
:
Fighting the antibiotic resistant serine-beta-lactamase OXA-48 - through altered ceftazidime activity or new inhibitors?
2019
Hanna-Kirsti S. Leiros
:
Antibiotika resistens er et globalt problem. Nye inhibitorer og velkjente antibiotika, kan de sammen bli ny behandlings metode?
2019
Adele Kim Williamson,
Erik Hjerde,
Aili Sarre,
Ingar Leiros,
Kristel Berg,
Hanna-Kirsti S. Leiros
:
Discovery and design of novel DNA ligases for biotechnology
2018
Christopher Frøhlich,
Vidar Sørum,
Hanna-Kirsti S. Leiros,
Pål Jarle Johnsen,
Ørjan Samuelsen
:
Development of OXA-48 mediated ceftazidme-avibactam resistance is associated with an evolutionary trade-off
2018
Hanna-Kirsti S. Leiros
:
Aiming for inhibitors towards beta-lactamases involved in antibiotic resistance, but starting with fragment screening. How is the progress?
2017
Hanna-Kirsti S. Leiros
:
Kampen. Den livsfarlige resistensen.
Hanna-Kirsti S. Leiros
:
Enzymer involvert i antibiotika resistens
Adele Kim Williamson,
Erik Hjerde,
Hanna-Kirsti S. Leiros,
Kjersti Lian,
Miguel A. Ramirez,
Wayne M. Patrick
:
Beyond T4: discovery and design of DNA ligases for use in biotechnological applications
2017
Hanna-Kirsti S. Leiros
:
Inhibitors can help fighting antibiotic resistance bacteria, but how do we find the best inhibitors?
2017
Hanna-Kirsti S. Leiros
:
Fragment screening used successfully for detecting OXA, VIM or NDM inhibitors
2017
Susann Skagseth,
Hanna-Kirsti S. Leiros
:
Forskere vil gjenreise effekten av antibiotika. https://forskning.no/kortnytt/forskere-vil-gjenreise-effekten-av-antibiotika
Vibeke Os,
Susann Skagseth,
Hanna-Kirsti S. Leiros
:
"Superbugs" skal ikke lengre få herje i fred, Vil gjenreise effekten av antibiotika.
Bjarte Aarmo Lund,
Hanna-Kirsti S. Leiros,
Annette Bayer,
Ørjan Samuelsen,
Tony Christopeit
:
The OXA-class of β-lactamases. A structural view on antibiotic resistance
2017
Annette Bayer,
Hanna-Kirsti S. Leiros,
Sundus Akhter,
Bjarte Aarmo Lund,
Tony Christopeit,
Aya Ismael
:
Towards Antibiotic Resistance Breakers: Fragment-Based Design of OXA- 48 Inhibitors
2017
Hanna-Kirsti S. Leiros
:
Searching for inhibitors towards beta-lactamases involved in antibiotic resistance, starting with fragment screening. Can we reach into the clinic?
2016